Synchronous dual primary ovarian and endometrial carcinomas
dc.contributor.author | Pearl, Michael L. | en_US |
dc.contributor.author | Johnston, Carolyn M. | en_US |
dc.contributor.author | Frank, Thomas S. | en_US |
dc.contributor.author | Roberts, James A. | en_US |
dc.date.accessioned | 2006-04-10T15:29:08Z | |
dc.date.available | 2006-04-10T15:29:08Z | |
dc.date.issued | 1993-12 | en_US |
dc.identifier.citation | Pearl, M. L., Johnston, C. M., Frank, T. S., Roberts, J. A. (1993/12)."Synchronous dual primary ovarian and endometrial carcinomas." International Journal of Gynecology & Obstetrics 43(3): 305-312. <http://hdl.handle.net/2027.42/30414> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T7M-4C4X6D0-C6/2/930c416c2a5741d69a93b299327b4630 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/30414 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7907042&dopt=citation | en_US |
dc.description.abstract | OBJECTIVES: The synchronous occurrence of carcinoma confined to the ovary and endometrium presents a diagnostic and therapeutic dilemma. These tumors have been variously staged as FIGO Stage IIA ovarian carcinoma, Stage III endometrial carcinoma, or synchronous dual primary carcinomas. Accumulating evidence suggests such patients have a favorable outcome. This retrospective study was undertaken to review our experience with these fascinating tumors. METHODS: The clinical records and the pathologic findings of 16 patients with synchronous dual primary ovarian and endometrial carcinomas were reviewed. RESULTS: The median age was 51 years. Abnormal uterine bleeding was the most common presenting symptom (70%). All patients had Stage I ovarian and endometrial carcinomas. Fourteen patients (88%) had endometrioid carcinoma in both sites, while two patients (12%) had dissimilar histology. For 15 patients (94%), the grade of both tumors was identical. Only three (19%) patients had myometrial invasion, with less than 50% involvement in each case. All patients underwent surgical staging, 11 (70%) of whom received adjuvant radiation or chemotherapy. The five patients treated with surgery alone had Grade 1 endometrioid tumors. The only relapse occurred in a patient with a clear cell component in both sites. No patient has died of disease. CONCLUSIONS: Patients with synchronous dual primary carcinomas appear to have a more favorable prognosis than that expected with Stage IIA ovarian or Stage III endometrial carcinoma (100% vs. 63% or 42% survival at 3 years, respectively). The excellent survival for patients with Grade 1 dual endometrioid tumors treated with surgery alone suggests that adjuvant therapy may not be necessary for this sub-group. | en_US |
dc.format.extent | 759735 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Synchronous dual primary ovarian and endometrial carcinomas | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Women's and Gender Studies | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbtoplevel | Social Sciences | en_US |
dc.subject.hlbtoplevel | Humanities | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Departments of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Michigan Medical Center, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Departments of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Michigan Medical Center, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Department of Pathology, Division of Gynecologic Oncology, University of Michigan Medical Center, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Departments of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Michigan Medical Center, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 7907042 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/30414/1/0000034.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0020-7292(93)90520-7 | en_US |
dc.identifier.source | International Journal of Gynecology & Obstetrics | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.